Insmed Inc. buy Wells Fargo & Company
Start price
22.07.25
/
50%
€88.00
Target price
22.07.26
€111.20
Performance (%)
-3.93%
Price
12.06.26
€82.80
Summary
This prediction is currently active. With a performance of -3.93%, the BUY prediction for Insmed Inc. by Wells_Fargo___Compan is down slightly. This prediction currently runs until 22.07.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Insmed Inc. | 1.471% | 1.471% |
| iShares Core DAX® | 0,27 % | 2,50 % |
| iShares Nasdaq 100 | 1,88 % | 3,49 % |
| iShares Nikkei 225® | 3,58 % | 8,13 % |
| iShares S&P 500 | 0,15 % | 1,92 % |
Comments by Wells_Fargo___Compan for this prediction
In the thread Insmed Inc. diskutieren
Insmed, Inc. (NASDAQ: INSM) had its price target raised by analysts at Wells Fargo & Company from $119.00 to $130.00. They now have an "overweight" rating on the stock.
Ratings data for INSM provided by MarketBeat